Pulse Biosciences, Inc. (PLSE) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
PLSE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
PLSE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -360.0% | -21982.6% | -20794.6% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | -1606.3% | -8293.9% | -8357.9% |
| 2021 | -38.8% | -4443.9% | -4489.4% |
Download Data
Export PLSE earnings history in CSV or JSON format
Free sign-in required to download data
Pulse Biosciences, Inc. (PLSE) Earnings Overview
As of May 8, 2026, Pulse Biosciences, Inc. (PLSE) reported trailing twelve-month net income of -$73M, reflecting -17.4% year-over-year growth. The company earned $-1.08 per diluted share over the past four quarters, with a net profit margin of -20794.6%.
Looking at the long-term picture, PLSE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$474,857 in fiscal 2014.
Pulse Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including INVA ($504M net income, 63.8% margin), NVCR (-$173M net income, -20.8% margin), ATEC (-$125M net income, -18.8% margin), PLSE has room to improve margins relative to the peer group. Compare PLSE vs INVA →
PLSE Earnings vs Peers
Earnings metrics vs comparable public companies
PLSE Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$73M | -35.8% | -$77M | $-1.08 | -20794.6% | -21982.6% |
| 2024 | -$54M | -26.9% | -$56M | $-0.92 | - | - |
| 2023 | -$42M | +27.9% | -$44M | $-0.88 | - | - |
| 2022 | -$59M | +8.1% | -$58M | $-1.72 | -8357.9% | -8293.9% |
| 2021 | -$64M | -28.0% | -$63M | $-2.28 | -4489.4% | -4443.9% |
| 2020 | -$50M | -8.2% | -$50M | $-2.14 | - | - |
| 2019 | -$46M | -22.5% | -$48M | $-2.22 | - | - |
| 2018 | -$38M | -46.8% | -$38M | $-2.20 | - | - |
| 2017 | -$26M | -168.6% | -$26M | $-1.73 | - | - |
| 2016 | -$10M | -238.6% | -$10M | $-0.86 | - | - |
See PLSE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PLSE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PLSE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPLSE — Frequently Asked Questions
Quick answers to the most common questions about buying PLSE stock.
Is PLSE growing earnings?
PLSE EPS fell to $-1.08, with earnings declining -17.4%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-73M.
What are PLSE's profit margins?
Pulse Biosciences, Inc. net margin is -20794.6%, with operating margin at -21982.6%. Below-average margins reflect competitive or cost pressures.
How consistent are PLSE's earnings?
PLSE earnings data spans 2014-2025. The declining earnings trend is -17.4% YoY. Historical data enables comparison across business cycles.